SDZ 51641

structure given in first source

Also Known As:

2-(1,1-dimethylethyl)-2-(4-methylphenyl)-1,3-dioxolane; SDZ-51641

Networked: 1 relevant articles (0 outcomes, 0 trials/studies)

1.	Type 2 Diabetes Mellitus (MODY) 11/01/1990 - "The new oral hypoglycemic agent SDZ 51641 was evaluated in nondiabetic rats and a rat model of human non-insulin-dependent diabetes mellitus. "

1.	Hypoglycemic Agents (Hypoglycemics)